Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
Author:
Affiliation:
1. York Health Economics Consortium, University of York, UK;
2. Pfizer Incorporated, Global Innovative Products, Groton, CT, USA;
3. Pfizer Incorporated, Global Innovative Products, Collegeville, PA, USA
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1497957
Reference45 articles.
1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007
3. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
4. Extra-articular manifestations of rheumatoid arthritis: An update
5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-11
2. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina;Revista Peruana de Medicina Experimental y Salud Pública;2024-06-21
3. Exploring CircRNA N6-methyladenosine in human rheumatoid arthritis: Hyper-methylated hsa_circ_0007259 as a potential biomarker and its involvement in the hsa_circ_0007259/hsa_miR-21-5p/STAT3 axis;International Immunopharmacology;2023-11
4. Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies;Expert Review of Pharmacoeconomics & Outcomes Research;2023-08-28
5. Sinomenine ameliorates adjuvant-induced arthritis by inhibiting the autophagy/NETosis/inflammation axis;Scientific Reports;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3